Abstract
Hydrocarbon aspiration causes acute lung injury, which may lead to acute respiratory distress syndrome. Surfactant has been shown to be beneficial in experimentally-induced hydrocarbon-associated acute respiratory distress syndrome. However, there has not been a clinical study evaluating the effect of surfactant application on hydrocarbon aspiration in humans. We report a 17-month-old boy with acute respiratory distress syndrome due to hydrocarbon aspiration and was successfully treated with surfactant application.
MeSH terms
-
Alkanes / poisoning*
-
Anti-Infective Agents / administration & dosage
-
Biological Products / administration & dosage*
-
Ceftriaxone / administration & dosage
-
Combined Modality Therapy
-
Critical Care
-
Dopamine / administration & dosage
-
Humans
-
Hydrocarbons / poisoning*
-
Infant
-
Male
-
Positive-Pressure Respiration
-
Pulmonary Surfactants / administration & dosage*
-
Radiography
-
Respiratory Aspiration / complications*
-
Respiratory Aspiration / diagnostic imaging
-
Respiratory Distress Syndrome / chemically induced*
-
Respiratory Distress Syndrome / diagnostic imaging
-
Respiratory Distress Syndrome / drug therapy*
-
Trachea
-
Turkey
Substances
-
Alkanes
-
Anti-Infective Agents
-
Biological Products
-
Hydrocarbons
-
Pulmonary Surfactants
-
Ceftriaxone
-
naphtha
-
beractant
-
Dopamine